Diabetes diagnosis during hospital presentations
Research type
Research Study
Full title
FINDing Patients With Unknown Diabetes During Hospital Presentation In Tameside General Hospital (FIND-IT)
IRAS ID
287393
Contact name
Edward Jude
Contact email
Sponsor organisation
Tameside and Glossop Integrated Care NHS FT
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 11 months, 30 days
Research summary
Type 2 diabetes (T2D) is increasing every year and in the UK there are around 4 million people with diabetes. However it is estimated that around 1 million are still undiagnosed. In addition there are many more with pre-diabetes. People with type 2 diabetes are 50% more likely to die prematurely than those without diabetes. Those with prediabetes are also at increased risk of cardiovascular disease. It is paramount that we identify those who are still undiagnosed to reduce the burden to the NHS. This can be done by early identification and early intervention. The latter can only be done if the former is successfully implemented. \nThe aim of our project is to see whether this is a simple method of identifying the many patients who have undiagnosed glucose intolerance and ensuring those who are identified are commenced on the right treatment path for them to reduce both individual risk and burden to the NHS.\nPatients presenting to A&E have routine bloods taken for condition which are they are being investigated and treated for. The study will involve conducting an HbA1c test in the blood and using cutoffs set by the National Institute for Clinical Excellence and Diabetes UK, to identify how many patients have an unknown diagnosis of diabetes or pre-diabetes. We will recruit 10,000 patients coming through A&E over the 12 months. In addition to measuring HbA1c we will look for other risk factors, such as socio economic status, obesity, ethnicity, weekly exercise patterns and other metabolic factors (e.g. lipids). All results will be forwarded to the GP with advice on management if HbA1c is raised and they will be advised to follow-up the patient. This will allow the patients’ GP to provide appropriate management of the diabetes according to NICE guidelines.\n
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
21/WM/0093
Date of REC Opinion
25 May 2021
REC opinion
Further Information Favourable Opinion